Enhanced therapeutic effects for human pancreatic cancer by application K-ras and IGF-IR antisense oligodeoxynucleotides

Figure 3 Each value represents the mean ± SD from triplicate determinations. A: Growth curves of Patu8988 cells treated with different concentrations of K-ras ASODN at different incubation times; B: Growth curves of Patu8988 cells treated with different concentrations of IGF-IR ASODN at different incubation times; C: Growth curves of Patu8988 cells treated with the combination treatment of 16 mg/L K-ras ASODN and 16 mg/L IGF-IR ASODN at different incubation times; D: The inhibition effect of the combination treatment with K-ras ASODN and IGF-IR ASODN on tumor growth in nude mice.